Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Glenn J. Hanna, Harita Dharanesswaran, Anita Giobbie‐Hurder, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 9, pp. 1021-1030
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients
Tess Van Meerhaeghe, Naoka Murakami, Alaín Le Moine, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 7
Corticosteroid premedication on anti-tumor effect of immune checkpoint blockade in murine hepatocellular carcinoma models
Ying‐Chun Shen, Nai-Wen Chang, Ching-Ping Yeh, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e009704-e009704
Open Access
Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients
Eyal Yosefof, Nofar Edri, Idan Ben-Nachum, et al.
The Oncologist (2025) Vol. 30, Iss. 2
Open Access
Combined standard immunosuppression and immune checkpoint inhibition for BKPyV+ metastatic renal cell carcinoma of the graft in a kidney transplant recipient with chronic rejection: a case report
Ilaria Gandolfini, Martina Manini, Giuseppe Daniele Benigno, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Treatment of metastatic melanoma with anti-PD-1 and anti-LAG-3 in a kidney transplant recipient
Janmesh Patel, Weixiong Zhong, Jefree J. Schulte, et al.
Immunotherapy (2025), pp. 1-6
Closed Access
Immune checkpoint inhibitors use in lung transplant recipients: a case series and systematic review of literature
N Mahmoud, G. Pamart, Charlée Nardin, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104537-104537
Open Access
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open
Urvashi Mitbander Joshi, Jasmin Hundal, Jonaphine Mata, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort
Jordi Remón, Édouard Auclin, Leyre Zubiri, et al.
ESMO Open (2024) Vol. 9, Iss. 5, pp. 103004-103004
Open Access | Times Cited: 3
Successful Treatment of Cutaneous Squamous Cell Cancer with Cemiplimab—A Report of Two Cases Demonstrating the Management of Pseudoprogression and Adverse Events
Paulina Żukowska, Katarzyna Ciepiela, Aleksandra Kudrymska, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4236-4236
Open Access | Times Cited: 2
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges
Luigi Lorini, Andrea Alberti, Paolo Bossi
Dermatology Practical & Conceptual (2023), pp. e2023251-e2023251
Open Access | Times Cited: 6
Exploring Costimulatory Blockade-Based Immunologic Strategies in Transplantation: Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?
Andreea Grosu-Bularda, Florin-Vlad Hodea, Dragoş Zamfirescu, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 322-322
Open Access | Times Cited: 2
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
Stephanie Ji, Hao Liu, Laura A. Pachella, et al.
Frontiers in Transplantation (2023) Vol. 2
Open Access | Times Cited: 4
Paraneoplastic Syndrome After Kidney Transplantation: Frequency, Risk Factors, Differences to Paraneoplastic Occurrence of Glomerulonephritis in the Native Kidney, and Implications on Long-Term Kidney Graft Function
Izabela Zakrocka, Gayatri Nair, María José Soler, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients
Sophie H. Li, Thomas Townes, Shorook Na’ara
Cancers (2024) Vol. 16, Iss. 18, pp. 3118-3118
Open Access | Times Cited: 1
Checkpoint Inhibition for Kidney Transplant Recipients With Advanced Cutaneous Carcinomas: An Emerging Standard for Select Patients
Shlomo A. Koyfman, J.L. Geiger
Journal of Clinical Oncology (2024) Vol. 42, Iss. 9, pp. 981-983
Closed Access
Neoadjuvant Immunotherapy in Non-melanoma Skin Cancers of the Head and Neck
Rami Ezzibdeh, Mohamed Diop, Vasu Divi
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 7, pp. 885-896
Closed Access
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
Spencer Lessans, Katie A. O’Connell, Jennifer H. Choe
Current Oncology Reports (2024) Vol. 26, Iss. 9, pp. 1120-1133
Open Access
Immunotherapy for Advanced Skin Cancer in Kidney Transplant Recipients—The High-Risk Balancing Act
Madeliene Stump, Sarah T. Arron, Charlotte M. Proby
JAMA Dermatology (2024) Vol. 160, Iss. 8, pp. 799-799
Closed Access
Exhaustion of T cells after renal transplantation
Xiujia Wang, Jinghui Zhang, Pingshan Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression
Karam Khaddour, Naoka Murakami, Emily S. Ruiz, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3083-3083
Open Access
Treatment of skin cancers in solid organ transplant recipients: current status and future perspectives
E. Ducroux, Jean Kanitakis
Expert Review of Anticancer Therapy (2024)
Closed Access
Immune Checkpoint Inhibitor Therapy for Kidney Transplant Recipients – A Review of Potential Complications and Management Strategies
Elena Bianca Barbir, Samer Abdulmoneim, Arkadiusz Z. Dudek, et al.
Transplant International (2024) Vol. 37
Open Access
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Nephrotoxicity: A Position Statement from the American Society of Onco-nephrology
Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Kidney International (2024)
Closed Access
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients
Miguel Bigotte Vieira, Hiroyuki Arai, Carla Nicolau, et al.
Kidney360 (2024) Vol. 5, Iss. 10, pp. 1569-1583
Open Access
Immunotherapy in the era of transplant oncology: Risks and complications
Bilal Anouti, Reham Abdel‐Wahab, Adi Diab
Elsevier eBooks (2024), pp. 135-147
Closed Access
Page 1 - Next Page

Scroll to top